1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea

C155H178N27O16+ — CID 161445905

IUPAC1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea
SMILESCC(C)(C)c1cc(CC(=O)Cc2ccc(C#CC3=CN=[N+]4C(OCCN5CCCCC5)=CC=NC34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4c(OCCCN5CCCCC5)ccnc34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4cc(OCCCN5CCCCC5)cnc34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4cc(OCCN5CCOCC5)cnc34)cc2)no1.CC(C)(C)c1cc(NC(=O)Nc2ccc(C#Cc3cnn4ccc(OCCCN5CCCCC5)nc34)cc2)no1
InChIInChI=1S/2C32H37N5O3.C31H36N5O3.C30H35N7O3.C30H33N5O4/c1-32(2,3)29-22-27(35-40-29)21-28(38)20-25-10-8-24(9-11-25)12-13-26-23-34-37-30(14-15-33-31(26)37)39-19-7-18-36-16-5-4-6-17-36;1-32(2,3)30-20-27(35-40-30)19-28(38)18-25-10-8-24(9-11-25)12-13-26-21-34-37-23-29(22-33-31(26)37)39-17-7-16-36-14-5-4-6-15-36;1-31(2,3)28-21-26(34-39-28)20-27(37)19-24-9-7-23(8-10-24)11-12-25-22-33-36-29(13-14-32-30(25)36)38-18-17-35-15-5-4-6-16-35;1-30(2,3)25-20-26(35-40-25)33-29(38)32-24-12-9-22(10-13-24)8-11-23-21-31-37-18-14-27(34-28(23)37)39-19-7-17-36-15-5-4-6-16-36;1-30(2,3)28-18-25(33-39-28)17-26(36)16-23-6-4-22(5-7-23)8-9-24-19-32-35-21-27(20-31-29(24)35)38-15-12-34-10-13-37-14-11-34/h8-11,14-15,22-23H,4-7,16-21H2,1-3H3;8-11,20-23H,4-7,14-19H2,1-3H3;7-10,13-14,21-22,30H,4-6,15-20H2,1-3H3;9-10,12-14,18,20-21H,4-7,15-17,19H2,1-3H3,(H2,32,33,35,38);4-7,18-21H,10-17H2,1-3H3/q;;+1;;
InChIKeyMBTXBEYQESBVSY-UHFFFAOYSA-N
MW2675.30 g/mol
LogP23.64
Rot. Bonds41

About 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea

1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea (PubChem CID 161445905) has the molecular formula C155H178N27O16+ and a molecular weight of 2675.30 g/mol. Its IUPAC name is 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea.

Molecular Properties

Compound Name1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea
PubChem CID161445905
Molecular FormulaC155H178N27O16+
Molecular Weight2675.30 g/mol
Exact Mass2673.39
IUPAC Name1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea
SMILESCC(C)(C)c1cc(CC(=O)Cc2ccc(C#CC3=CN=[N+]4C(OCCN5CCCCC5)=CC=NC34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4c(OCCCN5CCCCC5)ccnc34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4cc(OCCCN5CCCCC5)cnc34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4cc(OCCN5CCOCC5)cnc34)cc2)no1.CC(C)(C)c1cc(NC(=O)Nc2ccc(C#Cc3cnn4ccc(OCCCN5CCCCC5)nc34)cc2)no1
InChIInChI=1S/2C32H37N5O3.C31H36N5O3.C30H35N7O3.C30H33N5O4/c1-32(2,3)29-22-27(35-40-29)21-28(38)20-25-10-8-24(9-11-25)12-13-26-23-34-37-30(14-15-33-31(26)37)39-19-7-18-36-16-5-4-6-17-36;1-32(2,3)30-20-27(35-40-30)19-28(38)18-25-10-8-24(9-11-25)12-13-26-21-34-37-23-29(22-33-31(26)37)39-17-7-16-36-14-5-4-6-15-36;1-31(2,3)28-21-26(34-39-28)20-27(37)19-24-9-7-23(8-10-24)11-12-25-22-33-36-29(13-14-32-30(25)36)38-18-17-35-15-5-4-6-16-35;1-30(2,3)25-20-26(35-40-25)33-29(38)32-24-12-9-22(10-13-24)8-11-23-21-31-37-18-14-27(34-28(23)37)39-19-7-17-36-15-5-4-6-16-36;1-30(2,3)28-18-25(33-39-28)17-26(36)16-23-6-4-22(5-7-23)8-9-24-19-32-35-21-27(20-31-29(24)35)38-15-12-34-10-13-37-14-11-34/h8-11,14-15,22-23H,4-7,16-21H2,1-3H3;8-11,20-23H,4-7,14-19H2,1-3H3;7-10,13-14,21-22,30H,4-6,15-20H2,1-3H3;9-10,12-14,18,20-21H,4-7,15-17,19H2,1-3H3,(H2,32,33,35,38);4-7,18-21H,10-17H2,1-3H3/q;;+1;;
InChIKeyMBTXBEYQESBVSY-UHFFFAOYSA-N
XLogP23.64
TPSA459.63 Ų
H-Bond Donors2
H-Bond Acceptors40
Rotatable Bonds41
Heavy Atoms198
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002675.30
LogP ≤ 523.64
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea?
The IUPAC name of 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea (CID 161445905) is 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea.
What is the SMILES notation for 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea?
The canonical SMILES for 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea is CC(C)(C)c1cc(CC(=O)Cc2ccc(C#CC3=CN=[N+]4C(OCCN5CCCCC5)=CC=NC34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4c(OCCCN5CCCCC5)ccnc34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4cc(OCCCN5CCCCC5)cnc34)cc2)no1.CC(C)(C)c1cc(CC(=O)Cc2ccc(C#Cc3cnn4cc(OCCN5CCOCC5)cnc34)cc2)no1.CC(C)(C)c1cc(NC(=O)Nc2ccc(C#Cc3cnn4ccc(OCCCN5CCCCC5)nc34)cc2)no1.
What is the InChIKey of 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea?
The InChIKey is MBTXBEYQESBVSY-UHFFFAOYSA-N. The full InChI is InChI=1S/2C32H37N5O3.C31H36N5O3.C30H35N7O3.C30H33N5O4/c1-32(2,3)29-22-27(35-40-29)21-28(38)20-25-10-8-24(9-11-25)12-13-26-23-34-37-30(14-15-33-31(26)37)39-19-7-18-36-16-5-4-6-17-36;1-32(2,3)30-20-27(35-40-30)19-28(38)18-25-10-8-24(9-11-25)12-13-26-21-34-37-23-29(22-33-31(26)37)39-17-7-16-36-14-5-4-6-15-36;1-31(2,3)28-21-26(34-39-28)20-27(37)19-24-9-7-23(8-10-24)11-12-25-22-33-36-29(13-14-32-30(25)36)38-18-17-35-15-5-4-6-16-35;1-30(2,3)25-20-26(35-40-25)33-29(38)32-24-12-9-22(10-13-24)8-11-23-21-31-37-18-14-27(34-28(23)37)39-19-7-17-36-15-5-4-6-16-36;1-30(2,3)28-18-25(33-39-28)17-26(36)16-23-6-4-22(5-7-23)8-9-24-19-32-35-21-27(20-31-29(24)35)38-15-12-34-10-13-37-14-11-34/h8-11,14-15,22-23H,4-7,16-21H2,1-3H3;8-11,20-23H,4-7,14-19H2,1-3H3;7-10,13-14,21-22,30H,4-6,15-20H2,1-3H3;9-10,12-14,18,20-21H,4-7,15-17,19H2,1-3H3,(H2,32,33,35,38);4-7,18-21H,10-17H2,1-3H3/q;;+1;;.
What are the key properties of 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea?
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea has a molecular weight of 2675.30 g/mol, XLogP of 23.64, 41 rotatable bonds, 2 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(2-morpholin-4-ylethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(2-piperidin-1-ylethoxy)-3aH-pyrazolo[1,5-a]pyrimidin-8-ium-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[6-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[7-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]propan-2-one;1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[2-[5-(3-piperidin-1-ylpropoxy)pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]phenyl]urea is sourced from PubChem (CID 161445905), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).